OncoSil Medical Limited (ASX:OSL)
Australia flag Australia · Delayed Price · Currency is AUD
0.5200
-0.0300 (-5.45%)
Mar 18, 2026, 4:15 PM AEST

OncoSil Medical Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
2.855.114.59.3911.2812.24
Cash & Short-Term Investments
2.855.114.59.3911.2812.24
Cash Growth
-66.28%13.51%-52.08%-16.72%-7.84%-41.71%
Accounts Receivable
0.510.840.311.160.851.11
Other Receivables
2.750.361.120.120.060.08
Receivables
3.271.21.441.290.911.18
Prepaid Expenses
0.620.410.390.440.470.11
Other Current Assets
---0.120.090.09
Total Current Assets
6.746.726.3311.2312.7413.62
Property, Plant & Equipment
0.390.420.390.240.320.53
Total Assets
7.137.156.7211.4713.0714.15
Accounts Payable
1.481.921.120.960.931.23
Accrued Expenses
0.30.430.340.160.340.51
Current Portion of Leases
0.040.050.030.150.170.16
Other Current Liabilities
1.461.630.450.30.330.23
Total Current Liabilities
3.294.031.941.571.772.13
Long-Term Leases
-0.020.040.020.140.32
Total Liabilities
3.294.041.981.591.912.45
Common Stock
99.2596.4390.0986.5179.9170.4
Retained Earnings
-110.99-107.46-92.78-84.37-73.02-62.3
Comprehensive Income & Other
15.5714.147.427.744.283.6
Shareholders' Equity
3.843.14.749.8811.1611.7
Total Liabilities & Equity
7.137.156.7211.4713.0714.15
Total Debt
0.040.070.070.170.30.48
Net Cash (Debt)
2.815.044.439.2210.9811.76
Net Cash Growth
-66.50%13.75%-51.96%-15.97%-6.63%-43.72%
Net Cash Per Share
0.180.460.803.275.415.75
Filing Date Shares Outstanding
18.8114.228.334.942.481.99
Total Common Shares Outstanding
18.8114.228.334.942.481.99
Working Capital
3.452.74.399.6710.9811.49
Book Value Per Share
0.200.220.572.004.505.87
Tangible Book Value
3.843.14.749.8811.1611.7
Tangible Book Value Per Share
0.200.220.572.004.505.87
Machinery
0.10.090.10.12--
Construction In Progress
0.340.340.330.06--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.